Investigative ophthalmology & visual science · 2026
Clinical and Surgical Implications of Genotype-Phenotype Correlations in Congenital Ectopia Lentis: A Real-World Cohort Study.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Jia Wan-Nan, Chen Ze-Xu, Shen Xin, Wang Ya-Lei, Chen Xin-Yao, Xiao Yan-Bo, Li Lin-Zhao, Huo Qiu-Yi, Zhang Yu-Lin, Chen Tian-Hui, Zhang Min, Jiang Yong-Xiang
Аннотация
PURPOSE: To characterize the genetic landscape of congenital ectopia lentis (EL) and assess genotype-phenotype correlations with implications for surgical decision-making.
METHODS: This retrospective study enrolled patients with congenital EL who presented to Fudan University Eye and ENT Hospital between 2017 and 2025. We performed targeted next-generation sequencing for probands, with candidate variants confirmed by Sanger sequencing. Patients were categorized into FBN1 and non-FBN1 groups. The ocular features and surgical options were compared across genotypes.
RESULTS: A total of 497 probands were enrolled. The molecular diagnostic yield was 93.36%, with FBN1 variants accounting for 82.93% and non-FBN1 variants for 10.44%. Compared with FBN1 cases, non-FBN1 patients exhibited higher EL severity (P < 0.001), lower corneal curvature radius (CCR) (P < 0.001), and higher incidence of ocular comorbidities (P < 0.01). Surgically, non-FBN1 patients more often required robust intraocular lens fixation methods than did FBN1 patients (P < 0.001). Within the FBN1 cohort, the DN(Cys+CaB)+HI subgroup exhibited longer axial length (AL) (P < 0.001), thinner central corneal thickness (CCT) (P = 0.015), and a higher proportion of clinically diagnosed Marfan syndrome (P < 0.001) compared with the DN(Others) subgroup. In contrast, the FBN1 DN(Others) subgroup showed comparable AL, CCT, and CCR to the non-FBN1 group (all P > 0.05). No significant difference of ocular biometrics or surgical options were observed within the non-FBN1 group, except for the highest CCR in patients harboring CPAMD8 variants (P = 0.004).
CONCLUSIONS: Genetic characterization of congenital EL extends beyond diagnosis to inform ocular phenotype variability and surgical decision-making.
METHODS: This retrospective study enrolled patients with congenital EL who presented to Fudan University Eye and ENT Hospital between 2017 and 2025. We performed targeted next-generation sequencing for probands, with candidate variants confirmed by Sanger sequencing. Patients were categorized into FBN1 and non-FBN1 groups. The ocular features and surgical options were compared across genotypes.
RESULTS: A total of 497 probands were enrolled. The molecular diagnostic yield was 93.36%, with FBN1 variants accounting for 82.93% and non-FBN1 variants for 10.44%. Compared with FBN1 cases, non-FBN1 patients exhibited higher EL severity (P < 0.001), lower corneal curvature radius (CCR) (P < 0.001), and higher incidence of ocular comorbidities (P < 0.01). Surgically, non-FBN1 patients more often required robust intraocular lens fixation methods than did FBN1 patients (P < 0.001). Within the FBN1 cohort, the DN(Cys+CaB)+HI subgroup exhibited longer axial length (AL) (P < 0.001), thinner central corneal thickness (CCT) (P = 0.015), and a higher proportion of clinically diagnosed Marfan syndrome (P < 0.001) compared with the DN(Others) subgroup. In contrast, the FBN1 DN(Others) subgroup showed comparable AL, CCT, and CCR to the non-FBN1 group (all P > 0.05). No significant difference of ocular biometrics or surgical options were observed within the non-FBN1 group, except for the highest CCR in patients harboring CPAMD8 variants (P = 0.004).
CONCLUSIONS: Genetic characterization of congenital EL extends beyond diagnosis to inform ocular phenotype variability and surgical decision-making.